Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 379

1.

Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested.

Grayston JT, Belland RJ, Byrne GI, Kuo CC, Schachter J, Stamm WE, Zhong G.

Pathog Dis. 2015 Feb;73(1):1-9. doi: 10.1093/femspd/ftu015. Epub 2014 Dec 4. Review. No abstract available.

2.

The type 1 pili regulator gene fimX and pathogenicity island PAI-X as molecular markers of uropathogenic Escherichia coli.

Bateman SL, Stapleton AE, Stamm WE, Hooton TM, Seed PC.

Microbiology. 2013 Aug;159(Pt 8):1606-17. doi: 10.1099/mic.0.066472-0. Epub 2013 Jun 6.

3.

Endometrial histopathology in patients with laparoscopic proven salpingitis and HIV-1 infection.

Mugo NR, Kiehlbauch J, Kiviat N, Nguti R, Gichuhi JW, Stamm WE, Cohen CR.

Infect Dis Obstet Gynecol. 2011;2011:407057. doi: 10.1155/2011/407057. Epub 2011 Sep 20.

4.

Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.

Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, Yarova-Yarovaya Y, Fiedler T, Cox M, Stamm WE.

Clin Infect Dis. 2011 May;52(10):1212-7. doi: 10.1093/cid/cir183. Epub 2011 Apr 14.

5.

Family history and risk of recurrent cystitis and pyelonephritis in women.

Scholes D, Hawn TR, Roberts PL, Li SS, Stapleton AE, Zhao LP, Stamm WE, Hooton TM.

J Urol. 2010 Aug;184(2):564-9. doi: 10.1016/j.juro.2010.03.139. Epub 2010 Jun 19.

6.

Phylogenetic analysis of Chlamydia trachomatis Tarp and correlation with clinical phenotype.

Lutter EI, Bonner C, Holland MJ, Suchland RJ, Stamm WE, Jewett TJ, McClarty G, Hackstadt T.

Infect Immun. 2010 Sep;78(9):3678-88. doi: 10.1128/IAI.00515-10. Epub 2010 Jul 6.

7.

Genome sequencing of recent clinical Chlamydia trachomatis strains identifies loci associated with tissue tropism and regions of apparent recombination.

Jeffrey BM, Suchland RJ, Quinn KL, Davidson JR, Stamm WE, Rockey DD.

Infect Immun. 2010 Jun;78(6):2544-53. doi: 10.1128/IAI.01324-09. Epub 2010 Mar 22.

8.

Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women.

Hawn TR, Scholes D, Wang H, Li SS, Stapleton AE, Janer M, Aderem A, Stamm WE, Zhao LP, Hooton TM.

PLoS One. 2009 Dec 15;4(12):e8300. doi: 10.1371/journal.pone.0008300.

9.

Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.

Suchland RJ, Sandoz KM, Jeffrey BM, Stamm WE, Rockey DD.

Antimicrob Agents Chemother. 2009 Nov;53(11):4604-11. doi: 10.1128/AAC.00477-09. Epub 2009 Aug 17.

10.

Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women.

Czaja CA, Stamm WE, Stapleton AE, Roberts PL, Hawn TR, Scholes D, Samadpour M, Hultgren SJ, Hooton TM.

J Infect Dis. 2009 Aug 15;200(4):528-36. doi: 10.1086/600385.

11.

Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women.

Hawn TR, Scholes D, Li SS, Wang H, Yang Y, Roberts PL, Stapleton AE, Janer M, Aderem A, Stamm WE, Zhao LP, Hooton TM.

PLoS One. 2009 Jun 22;4(6):e5990. doi: 10.1371/journal.pone.0005990.

12.

Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli.

Henderson JP, Crowley JR, Pinkner JS, Walker JN, Tsukayama P, Stamm WE, Hooton TM, Hultgren SJ.

PLoS Pathog. 2009 Feb;5(2):e1000305. doi: 10.1371/journal.ppat.1000305. Epub 2009 Feb 20.

13.

Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing.

Skinner MC, Stamm WE, Lampe ML.

Antimicrob Agents Chemother. 2009 Apr;53(4):1482-9. doi: 10.1128/AAC.01179-08. Epub 2009 Feb 2.

14.

Urinary tract infections in women with type 1 diabetes mellitus: survey of female participants in the epidemiology of diabetes interventions and complications study cohort.

Czaja CA, Rutledge BN, Cleary PA, Chan K, Stapleton AE, Stamm WE; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

J Urol. 2009 Mar;181(3):1129-34; discussion 1134-5. doi: 10.1016/j.juro.2008.11.021. Epub 2009 Jan 18.

15.

Rifalazil retains activity against rifampin-resistant mutants of Chlamydia pneumoniae.

Rothstein DM, Suchland RJ, Xia M, Murphy CK, Stamm WE.

J Antibiot (Tokyo). 2008 Aug;61(8):489-95. doi: 10.1038/ja.2008.65.

PMID:
18997387
16.

Identification of concomitant infection with Chlamydia trachomatis IncA-negative mutant and wild-type strains by genomic, transcriptional, and biological characterizations.

Suchland RJ, Jeffrey BM, Xia M, Bhatia A, Chu HG, Rockey DD, Stamm WE.

Infect Immun. 2008 Dec;76(12):5438-46. doi: 10.1128/IAI.00984-08. Epub 2008 Oct 13.

17.

What about the men?

Dunne EF, Gift TL, Stamm WE.

Sex Transm Dis. 2008 Nov;35(11 Suppl):S1-2. doi: 10.1097/OLQ.0b013e31818af142. No abstract available.

PMID:
18813144
18.

Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis.

Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ; EMERGEncy ID NET Study Group.

Clin Infect Dis. 2008 Nov 1;47(9):1150-8. doi: 10.1086/592250.

PMID:
18808361
19.

Theodore E. Woodward Award: host-pathogen interactions in community-acquired urinary tract infections.

Stamm WE.

Trans Am Clin Climatol Assoc. 2006;117:75-83; discussion 83-4. Review.

20.

Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women.

Czaja CA, Stapleton AE, Yarova-Yarovaya Y, Stamm WE.

Infect Dis Obstet Gynecol. 2007;2007:35387. doi: 10.1155/2007/35387.

21.

Detection of intracellular bacterial communities in human urinary tract infection.

Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ.

PLoS Med. 2007 Dec;4(12):e329.

22.

Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women.

Gupta K, Hooton TM, Roberts PL, Stamm WE.

Arch Intern Med. 2007 Nov 12;167(20):2207-12.

PMID:
17998493
23.

Population-based epidemiologic analysis of acute pyelonephritis.

Czaja CA, Scholes D, Hooton TM, Stamm WE.

Clin Infect Dis. 2007 Aug 1;45(3):273-80. Epub 2007 Jun 19.

PMID:
17599303
24.
25.

Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin.

Weissman SJ, Beskhlebnaya V, Chesnokova V, Chattopadhyay S, Stamm WE, Hooton TM, Sokurenko EV.

Infect Immun. 2007 Jul;75(7):3548-55. Epub 2007 May 14. Erratum in: Infect Immun. 2009 Apr;77(4):1720.

26.

Evaluating guidelines.

Stamm WE.

Clin Infect Dis. 2007 Mar 15;44(6):775-6. Epub 2007 Feb 1. No abstract available.

PMID:
17304446
27.

A randomized, double-blind study comparing single-dose rifalazil with single-dose azithromycin for the empirical treatment of nongonococcal urethritis in men.

Stamm WE, Batteiger BE, McCormack WM, Totten PA, Sternlicht A, Kivel NM; Rifalazil Study Group.

Sex Transm Dis. 2007 Aug;34(8):545-52.

PMID:
17297383
28.

Estrogens and urinary-tract infection.

Stamm WE.

J Infect Dis. 2007 Mar 1;195(5):623-4. Epub 2007 Jan 18. No abstract available.

PMID:
17262702
29.

Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation.

Garofalo CK, Hooton TM, Martin SM, Stamm WE, Palermo JJ, Gordon JI, Hultgren SJ.

Infect Immun. 2007 Jan;75(1):52-60. Epub 2006 Oct 30.

30.

Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection.

Kwok L, Stapleton AE, Stamm WE, Hillier SL, Wobbe CL, Gupta K.

J Urol. 2006 Nov;176(5):2050-4; discussion 2054.

PMID:
17070251
31.

Clonal isolation of chlamydia-infected cells using flow cytometry.

Alzhanov DT, Suchland RJ, Bakke AC, Stamm WE, Rockey DD.

J Microbiol Methods. 2007 Jan;68(1):201-8. Epub 2006 Sep 25.

PMID:
16997404
33.

Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis.

Mugo NR, Kiehlbauch JA, Nguti R, Meier A, Gichuhi JW, Stamm WE, Cohen CR.

Obstet Gynecol. 2006 Apr;107(4):807-12.

PMID:
16582116
34.

Population-based genetic epidemiologic analysis of Chlamydia trachomatis serotypes and lack of association between ompA polymorphisms and clinical phenotypes.

Millman K, Black CM, Stamm WE, Jones RB, Hook EW 3rd, Martin DH, Bolan G, Tavaré S, Dean D.

Microbes Infect. 2006 Mar;8(3):604-11. Epub 2006 Jan 5.

PMID:
16527508
35.

Rifalazil pretreatment of mammalian cell cultures prevents subsequent Chlamydia infection.

Suchland RJ, Brown K, Rothstein DM, Stamm WE.

Antimicrob Agents Chemother. 2006 Feb;50(2):439-44.

36.

Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis.

Cohen CR, Mugo NR, Astete SG, Odondo R, Manhart LE, Kiehlbauch JA, Stamm WE, Waiyaki PG, Totten PA.

Sex Transm Infect. 2005 Dec;81(6):463-6.

37.

Chlamydia trachomatis variant with nonfusing inclusions: growth dynamic and host-cell transcriptional response.

Xia M, Suchland RJ, Bumgarner RE, Peng T, Rockey DD, Stamm WE.

J Infect Dis. 2005 Oct 1;192(7):1229-36. Epub 2005 Aug 25.

PMID:
16136466
38.

Activities of rifamycin derivatives against wild-type and rpoB mutants of Chlamydia trachomatis.

Xia M, Suchland RJ, Carswell JA, Van Duzer J, Buxton DK, Brown K, Rothstein DM, Stamm WE.

Antimicrob Agents Chemother. 2005 Sep;49(9):3974-6.

39.

Development of secondary inclusions in cells infected by Chlamydia trachomatis.

Suchland RJ, Rockey DD, Weeks SK, Alzhanov DT, Stamm WE.

Infect Immun. 2005 Jul;73(7):3954-62.

40.

Significant reduction in inflammatory response in the macaque model of chlamydial pelvic inflammatory disease with azithromycin treatment.

Patton DL, Sweeney YT, Stamm WE.

J Infect Dis. 2005 Jul 1;192(1):129-35. Epub 2005 May 25.

PMID:
15942902
41.

Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis.

Gupta K, Hooton TM, Stamm WE.

J Antimicrob Chemother. 2005 Jul;56(1):243-6. Epub 2005 May 23.

PMID:
15911548
42.

Rifampin-resistant RNA polymerase mutants of Chlamydia trachomatis remain susceptible to the ansamycin rifalazil.

Suchland RJ, Bourillon A, Denamur E, Stamm WE, Rothstein DM.

Antimicrob Agents Chemother. 2005 Mar;49(3):1120-6.

43.

Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.

Hooton TM, Scholes D, Gupta K, Stapleton AE, Roberts PL, Stamm WE.

JAMA. 2005 Feb 23;293(8):949-55.

PMID:
15728165
44.

Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.

Wang SA, Papp JR, Stamm WE, Peeling RW, Martin DH, Holmes KK.

J Infect Dis. 2005 Mar 15;191(6):917-23. Epub 2005 Feb 11. Review.

PMID:
15717267
45.

Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.

Golden MR, Whittington WL, Handsfield HH, Hughes JP, Stamm WE, Hogben M, Clark A, Malinski C, Helmers JR, Thomas KK, Holmes KK.

N Engl J Med. 2005 Feb 17;352(7):676-85.

46.

Impact of patient characteristics on performance of nucleic acid amplification tests and DNA probe for detection of Chlamydia trachomatis in women with genital infections.

Marrazzo JM, Johnson RE, Green TA, Stamm WE, Schachter J, Bolan G, Hook EW 3rd, Jones RB, Martin DH, St Louis ME, Black CM.

J Clin Microbiol. 2005 Feb;43(2):577-84.

47.

Risk factors associated with acute pyelonephritis in healthy women.

Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, Stamm WE.

Ann Intern Med. 2005 Jan 4;142(1):20-7.

48.

Urologic complications of diabetes.

Brown JS, Wessells H, Chancellor MB, Howards SS, Stamm WE, Stapleton AE, Steers WD, Van Den Eeden SK, McVary KT.

Diabetes Care. 2005 Jan;28(1):177-85. Review. No abstract available.

PMID:
15616253
49.

Positive predictive value of Gen-Probe APTIMA Combo 2 testing for Neisseria gonorrhoeae in a population of women with low prevalence of N. gonorrhoeae infection.

Golden MR, Hughes JP, Cles LE, Crouse K, Gudgel K, Hu J, Swenson PD, Stamm WE, Handsfield HH.

Clin Infect Dis. 2004 Nov 1;39(9):1387-90. Epub 2004 Oct 11.

PMID:
15494917
50.

Chlamydia screening: expanding the scope.

Stamm WE.

Ann Intern Med. 2004 Oct 5;141(7):570-2. No abstract available.

PMID:
15466776

Supplemental Content

Loading ...
Support Center